Rab 7L1 inhibitors belong to a specific chemical class designed to modulate cellular processes by targeting the Rab 7L1 protein. Rab 7L1 is a member of the Rab family of small GTPases, playing a crucial role in intracellular vesicular trafficking and endosomal maturation. These inhibitors are meticulously designed molecules aimed at selectively impeding the function of Rab 7L1, thereby disrupting its involvement in cellular pathways. The Rab family of GTPases, including Rab 7L1, orchestrates the trafficking of vesicles within cells, regulating crucial processes such as endocytosis, phagocytosis, and autophagy.
Rab 7L1 inhibitors are characterized by their ability to interact with the active site of Rab 7L1, preventing its proper activation through the hydrolysis of GTP to GDP. This interaction hampers the normal cycling of Rab 7L1 between its active and inactive states, leading to perturbations in the endocytic and autophagic pathways. By modulating Rab 7L1 activity, these inhibitors offer a unique tool for researchers to dissect the intricate mechanisms of vesicular trafficking within cells. Understanding these processes at a molecular level provides valuable insights into cellular dynamics and may uncover potential avenues for further research in cell biology and related fields. The development and utilization of Rab 7L1 inhibitors contribute significantly to the exploration of fundamental cellular mechanisms, shedding light on the intricate orchestration of vesicular transport within the dynamic landscape of the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-(Benzoylcarbamothioylamino)-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic Acid | 314042-01-8 | sc-503400 | 10 mg | $300.00 | ||
Small molecule that can interfere with the function of Rab GTPases by inhibiting their prenylation. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Cdc42 GTPase inhibitor that can disrupt the signaling pathways Rab proteins are part of. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
Inhibitor of cytohesins, affecting ARF GTPases and indirectly influencing Rab protein signaling. | ||||||
CASIN | 425399-05-9 | sc-397016 | 10 mg | $460.00 | 1 | |
Cdc42 activity-specific inhibitor that can modulate pathways involving Rab GTPases. | ||||||
ZCL278 | 587841-73-4 | sc-507369 | 10 mg | $115.00 | ||
Cdc42 inhibitor that can alter the cytoskeletal organization affecting Rab protein-dependent trafficking. | ||||||
ITX 3 | 347323-96-0 | sc-295214 sc-295214A | 10 mg 50 mg | $145.00 $615.00 | ||
Inhibitor of Trio, a guanine nucleotide exchange factor, potentially affecting Rab protein signaling. | ||||||
EHT 1864 | 754240-09-0 | sc-361175 sc-361175A | 10 mg 50 mg | $213.00 $889.00 | 12 | |
Rac1 inhibitor that can indirectly influence Rab protein-mediated vesicular trafficking. | ||||||
Lonafarnib | 193275-84-2 | sc-482730 sc-482730A | 5 mg 10 mg | $173.00 $234.00 | ||
Farnesyltransferase inhibitor that can impair the proper localization and function of Rab proteins. | ||||||